Janssen Biotech, Inc.
Janssen Biotech, Inc. is listed as the manufacturer on 4 FDA drug label records covering 4 distinct active ingredients predominantly human prescription drug products.
About Janssen Biotech, Inc.
Janssen Biotech, Inc. is named as the labeler on 4 FDA drug label records. Its catalogue spans 4 distinct active ingredients, led by AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT), LAZERTINIB, NIPOCALIMAB-AAHU, USTEKINUMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: egfr exon, pediatric patients, years age, treatment adult, locally advanced, substitution mutations, detected fda-approved, metastatic nsclc. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 1 |
| LAZERTINIB | 1 |
| NIPOCALIMAB-AAHU | 1 |
| USTEKINUMAB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 2 |
| — | — | ORAL | 1 |
| — | — | SUBCUTANEOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Janssen Biotech, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| IMAAVY | NIPOCALIMAB-AAHU | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| LAZCLUZE | LAZERTINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Rybrevant Faspro | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Stelara | USTEKINUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
Frequently asked questions
How many FDA drug products does Janssen Biotech, Inc. make?
4 FDA drug label records name Janssen Biotech, Inc. as the manufacturer, covering 4 distinct active ingredients.
What active ingredients does Janssen Biotech, Inc. produce?
The most frequent active ingredients in this portfolio are AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT), LAZERTINIB, NIPOCALIMAB-AAHU, USTEKINUMAB.
Are Janssen Biotech, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.